04.23.22 -- Increasing mRNA Capabilities And Capacity For Growing Market Needs

The growing mRNA vaccine market ― projected to reach $127.3 billion by 2027 ― is fueling high demand for mRNA, which has resulted in a critical need to address mRNA manufacturing bottlenecks.

Size exclusion chromatography is the go-to analytical method for therapeutic protein drugs. This article describes the factors affecting the reproducibility of columns and how you can minimize column variation.

In this technical note, we describe the development of novel CE-LIF based methods for accurate determination of size purity of AAV genome.

Explore the importance of fate and purge studies, which measure the ability of the process to remove impurities and provide evidence of their removal.

Despite advances in technology that have improved the productivity, performance, and predictability of scientific work in laboratories, data compatibility problems persist. Systems, applications, and devices lack a standard way to share information with each other. An informatics platform that offers a software-automated, standardized instrument integration services solution is available.

Understand how the supply chain experience, severely affected by COVID-19, involving global workforce disruption, surging demand, and drug shortage notices, is shaping attitudes toward resilience.

Dr. Noel Smith, Ph.D., head of immunology at Lonza, answers attendee questions from a webinar about how to overcome challenges with immunogenicity and immunotoxicity assessments in drug development.